Pair Name | Aloin, Metformin | ||
Phytochemical Name | Aloin (PubChem CID: 12305761 ) | ||
Anticancer drug Name | Metformin (PubChem CID: 4091 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Aloin, Metformin | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->Autophagy | |||
Gene Regulation | Up-regulation | Activity | AKT1 | hsa207 |
Up-regulation | Activity | MTOR | hsa2475 | |
Up-regulation | Activity | PIK3CA | hsa5290 | |
In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
BEL-7402 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_5492 | |
In Vivo Model | For xenograft study, mice were inoculated subcutaneously into the right-back with 7.5×10⁶ HepG2 cells in 200 μl PBS and Matrigel (1:1). | |||
Result | Our research demonstrated that the concomitant treatment with aloin and MET enhances the antitumor effect by inhibiting the growth and invasion as well as inducing apoptosis and autophagy in HCC through PI3K/AKT/mTOR pathway. |
No. | Title | Href |
---|---|---|
1 | Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway. Cancer Med. 2020 Feb;9(3):1141-1151. doi: 10.1002/cam4.2723. | Click |